These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19155313)
1. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy. Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331 [TBL] [Abstract][Full Text] [Related]
5. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts. Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799 [TBL] [Abstract][Full Text] [Related]
6. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs. Patties I; Kortmann RD; Menzel F; Glasow A J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342 [TBL] [Abstract][Full Text] [Related]
7. Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. Lynch CA; Tycko B; Bestor TH; Walsh CP Mol Cancer; 2002 Jul; 1():2. PubMed ID: 12234381 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. Mongan NP; Gudas LJ Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557 [TBL] [Abstract][Full Text] [Related]
9. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Luszczek W; Cheriyath V; Mekhail TM; Borden EC Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643 [TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325 [TBL] [Abstract][Full Text] [Related]
11. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts. Gozzini A; Santini V Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241 [TBL] [Abstract][Full Text] [Related]
12. Unbalanced overexpression of the mutant allele in murine Patched mutants. Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144 [TBL] [Abstract][Full Text] [Related]
13. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Gore SD; Baylin S; Sugar E; Carraway H; Miller CB; Carducci M; Grever M; Galm O; Dauses T; Karp JE; Rudek MA; Zhao M; Smith BD; Manning J; Jiemjit A; Dover G; Mays A; Zwiebel J; Murgo A; Weng LJ; Herman JG Cancer Res; 2006 Jun; 66(12):6361-9. PubMed ID: 16778214 [TBL] [Abstract][Full Text] [Related]
14. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Müller U; Samson E; Quintanilla-Martinez L; Zimmer A J Biol Chem; 2000 Sep; 275(37):28341-4. PubMed ID: 10884376 [TBL] [Abstract][Full Text] [Related]
15. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
17. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Steele N; Finn P; Brown R; Plumb JA Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094 [TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells. Oi S; Natsume A; Ito M; Kondo Y; Shimato S; Maeda Y; Saito K; Wakabayashi T J Neurooncol; 2009 Mar; 92(1):15-22. PubMed ID: 19030781 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the PTCH coding region in human rhabdomyosarcoma. Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003 [TBL] [Abstract][Full Text] [Related]
20. PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation. Venza I; Visalli M; Fortunato C; Ruggeri M; Ratone S; Caffo M; Caruso G; Alafaci C; Tomasello F; Teti D; Venza M Epigenetics; 2012 Nov; 7(11):1315-30. PubMed ID: 23051921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]